Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Randomized trial of adjuvant zoledronic acid in postmenopausal women with high-risk breast cancer.

Leal T, Tevaarwerk A, Love R, Stewart J, Binkley N, Eickhoff J, Parrot B, Mulkerin D.

Clin Breast Cancer. 2010 Dec 1;10(6):471-6. doi: 10.3816/CBC.2010.n.062.

3.

The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trials.

Yan T, Yin W, Zhou Q, Zhou L, Jiang Y, Du Y, Shao Z, Lu J.

Eur J Cancer. 2012 Jan;48(2):187-95. doi: 10.1016/j.ejca.2011.10.021. Epub 2011 Nov 17. Review.

PMID:
22100904
4.

Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis.

He M, Fan W, Zhang X.

J Hematol Oncol. 2013 Oct 23;6(1):80. doi: 10.1186/1756-8722-6-80. Review.

5.
6.

Zoledronic acid in the treatment of early-stage breast cancer: is there a final verdict?

Gnant M.

Curr Oncol Rep. 2012 Feb;14(1):35-43. doi: 10.1007/s11912-011-0209-5. Review.

PMID:
22113793
7.

Treatment for osteoporosis in people with ß-thalassaemia.

Bhardwaj A, Swe KM, Sinha NK, Osunkwo I.

Cochrane Database Syst Rev. 2016 Mar 10;3:CD010429. doi: 10.1002/14651858.CD010429.pub2. Review.

PMID:
26964506
8.

Women and bone health: maximizing the benefits of aromatase inhibitor therapy.

Tang SC.

Oncology. 2010;79(1-2):13-26. doi: 10.1159/000314997. Epub 2010 Nov 3. Review.

PMID:
21051913
9.

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline.

Dhesy-Thind S, Fletcher GG, Blanchette PS, Clemons MJ, Dillmon MS, Frank ES, Gandhi S, Gupta R, Mates M, Moy B, Vandenberg T, Van Poznak CH.

J Clin Oncol. 2017 Jun 20;35(18):2062-2081. doi: 10.1200/JCO.2016.70.7257. Epub 2017 Mar 6. Review.

PMID:
28618241
10.

Bone Modifier Use as Adjuvant Therapy for Early Breast Cancer.

Ethier JL, Prince RM, Amir E.

Curr Oncol Rep. 2017 Mar;19(3):15. doi: 10.1007/s11912-017-0577-6. Review.

PMID:
28251493

Supplemental Content

Support Center